These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 6966309)

  • 41. Role of major histocompatibility complex gene products in delayed-type hypersensitivity.
    Miller JF; Vadas MA; Whitelaw A; Gamble J
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2486-90. PubMed ID: 1084997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutaneous delayed type hypersensitivity in SCID mice adoptively transferred with lymphocytes is B cell independent and H-2 restricted.
    Taube M; Carlsten H
    Scand J Immunol; 1997 May; 45(5):515-20. PubMed ID: 9160096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice.
    Askenase PW; Van Loveren H; Kraeuter-Kops S; Ron Y; Meade R; Theoharides TC; Nordlund JJ; Scovern H; Gerhson MD; Ptak W
    J Immunol; 1983 Dec; 131(6):2687-94. PubMed ID: 6605986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delayed-type hypersensitivity to allogeneic mouse epidermal cell antigens. III. Analysis of suppressor cells.
    Ishii N; Kawaguchi H; Aoki I; Takahashi T; Okuda K; Nakajima H
    Exp Clin Immunogenet; 1987; 4(1):48-55. PubMed ID: 2978839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Local cellular defenses in influenza-infected lungs.
    Stein-Streilein J; Witte PL; Streilein JW; Guffee J
    Cell Immunol; 1985 Oct; 95(2):234-46. PubMed ID: 3876158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Local passive transfer of delayed-type hypersensitivity in the mouse.
    Scovern H; Kantor FS
    J Immunol; 1982 Jul; 129(1):25-9. PubMed ID: 6177751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs.
    Clatch RJ; Lipton HL; Miller SD
    J Immunol; 1986 Feb; 136(3):920-7. PubMed ID: 2416841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD; Butler LD
    J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of delayed-type hypersensitivity. VII. The role of I-J subregion gene products in the inhibition of delayed-type hypersensitivity to major histocompatibility antigens by specific suppressor T cells.
    Liew FY
    Eur J Immunol; 1981 Nov; 11(11):883-8. PubMed ID: 6173227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Secondary delayed type hypersensitivity to H-2 subregion-coded alloantigens.
    Bianchi AT; Hussaarts-Odijk LM; Benner R
    Immunobiology; 1985 Sep; 170(3):192-202. PubMed ID: 3863787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.
    Dhaliwal JS; Liew FY
    Infect Immun; 1987 Mar; 55(3):645-51. PubMed ID: 3818088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.
    Scherle PA; Palladino G; Gerhard W
    J Immunol; 1992 Jan; 148(1):212-7. PubMed ID: 1530795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cells mediating graft rejection in the mouse. IV. The Ly-5, 6, and 8 effector cell phenotype.
    Loveland BE; McKenzie IF
    Transplantation; 1982 Apr; 33(4):411-3. PubMed ID: 6978559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Genetic restriction of delayed-type hypersensitivity to tuberculin in mice].
    Nikonenko BV; Mezhlumova MB; Moroz AM; Apt AS
    Genetika; 1988 Sep; 24(9):1707-9. PubMed ID: 3197966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
    Matsushima GK; Stohlman SA
    J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of cell mediated immunity in influenza virus infection in mice.
    Schulman JL; Petigrow C; Woodruff J
    Dev Biol Stand; 1977 Jun 1-3; 39():385-90. PubMed ID: 304820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recognition of noninfectious influenza virus by class I-restricted murine cytotoxic T lymphocytes.
    Hosaka Y; Sasao F; Yamanaka K; Bennink JR; Yewdell JW
    J Immunol; 1988 Jan; 140(2):606-10. PubMed ID: 2826596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antigen-specific suppression of delayed type hypersensitivity to murine cytomegalovirus in MCMV-infected mice.
    Chong KT; Mims CA
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2433-9. PubMed ID: 6315864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delayed-type hypersensitivity and allograft rejection in the mouse: correlation of effector cell phenotype.
    Loveland BE; McKenzie IF
    Immunology; 1982 Jun; 46(2):313-20. PubMed ID: 7044959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Macrophage procoagulant-inducing activity of influenza-specific effector T cells.
    Schiltknecht E; Ada GL; Braciale TJ
    Cell Immunol; 1984 Dec; 89(2):342-54. PubMed ID: 6334563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.